Medication info
Pimaone S Tablet 60/2.5 mg (Pimasartan, Amlodipine)

Pimaone S Tablet 60/2.5 mg (Pimasartan, Amlodipine)

Prescription medicationTabletOral
Ingredient · strength
S-Amlodipine Besylate Dihydrate›3.69mg / 1 tabletFimasartan Potassium Trihydrate›66.01mg / 1 tablet
Manufacturer / importer
Hana Pharm Co., Ltd.
Appearance
Yellow, rounded square-shaped film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle
Approval status
Active

MFDS item code 202204664 · Approved 2022.12.27 · Insurance code 657807840

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.

Ingredients

Manufacturer
Hana Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Pimasartan potassium is used primarily in patients with essential hypertension who do not adequately control blood pressure with monotherapy, assisting in blood pressure management. This medication dilates blood vessels and lowers blood pressure, effectively reducing the risk of cardiovascular disease. Therefore, pimasartan potassium contributes to improved hypertension treatment and maintaining health.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using fimasartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this medication's active ingredients or similar drugs, those who are pregnant or breastfeeding, patients undergoing kidney dialysis, those with moderate to severe liver impairment, those with bile duct obstruction, diabetic patients with certain kidney diseases, and those with specific genetic lactose intolerance should not take this medication. Patients with low blood volume or sodium in their body, those with impaired kidney function, those with renovascular hypertension, patients with heart diseases such as aortic or mitral stenosis, patients with primary aldosteronism, severe hypotension, the elderly, and those who are allergic to certain dyes included in this medication should take this medication cautiously. This medication may cause side effects such as dizziness, headaches, facial swelling, urinary disturbances, insomnia, and flushing, and may rarely cause severe kidney problems or blood pressure drops, so any unusual symptoms should be discussed with medical staff immediately. Patients with hypotension or electrolyte imbalances need to carefully manage their condition before taking this medication and should regularly check blood pressure and potassium levels during treatment. This medication may interact with other antihypertensives, potassium-sparing diuretics, certain antibiotics, pain relievers, etc., so if you are taking any other medications, be sure to inform your healthcare provider and exercise caution. Pregnant or breastfeeding women should avoid taking this medication, especially from the early stages of pregnancy. Children under 18 should avoid taking this medication since its safety and effectiveness have not been established. In the case of overdose, severe hypotension or heart rhythm abnormalities may occur, so it is essential to adhere to the prescribed dosage, and if an overdose occurs, visit a hospital immediately. This medicine should be kept out of reach of children and should not be transferred to another container, as this can lead to deterioration in quality or accidents.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial edema
  • peripheral edema
  • urinary disorders
  • insomnia
  • flushing
  • syncope
  • sedation
Show 133 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal rigidity
  • pruritus
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening of cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified type
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pneumonitis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening of low back pain
  • osteoarthritis
  • arthropathy
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • cerebral infarction
  • fracture
  • chest pain
  • weakness
  • fatigue
  • pain
  • weight gain/loss
  • hypotension
  • vasculitis
  • anxiety
  • sensory loss
  • dysesthesia
  • peripheral neuropathy
  • taste disorder
  • tremor
  • extrapyramidal disorder
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • hyperglycemia
  • joint pain
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • mood changes
  • dyspnea
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • nocturia
  • hepatitis
  • jaundice
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • skin erythema
  • maculopapular rash
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a tightly sealed container that blocks light. Additionally, it is advisable to store the medication at room temperature, ideally between 1 to 30 degrees Celsius. This helps maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Yellow, rounded square-shaped film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.